Department of Pediatric Hematology, Ege University, Faculty of Medicine, Izmir, Turkey.
Haemophilia. 2010 May;16(3):474-8. doi: 10.1111/j.1365-2516.2009.02167.x. Epub 2009 Dec 28.
Radioisotope synovectomy (RS) is defined as the intra-articular injection of radioisotopic agents with the aim of fibrosis on hypertrophic synovium in the target joint. The aim of this study was to investigate genotoxic effects on lymphocytes and malign transformation induced by Yttrium(90) (Y(90)) and Rhenium(186) (Re(186)) in children with haemophilia undergone RS. Forty haemophilia patients were enrolled. The mean age was 16.4 +/- 6.2 years (range: 8-40). Y(90) was used for knees, Re(186) was used for other joints. For safety, cytogenetic analysis was performed to determine potential chromosomal changes after RS procedure at three different time points as prior to procedure, 3rd day and 90th day. For the stimulation of chromosomal breakages, diepoxybutane was used (DEB test). Chromosomal breakages (CBs) were found in 23 patients (67.6%) prior to RS. We have found CBs additionally in nine of 11 patients who had no CBs prior to RS after 3 days of radioisotope exposure. At that time, the patients who had CBs were 29 (85.2%). At day 90, only 21 patients revealed (61.7%) CBs. The mean frequency of CBs slightly but not significantly increased in the 3rd day. However, there was a significant decreasing trend between 3rd and 90th days. Radioisotope synovectomy with Y(90) and Re(186) does not seem to induce the genotoxic effects significantly on peripheral blood lymphocytes. However, CBs even after one year in the re-evaluation of four patients, significant decrease in the number of CBs between the 3rd and 90th days and de novo CBs after exposure may be accepted as warning signals for young population. It should also be pointed out that families and patients be informed properly related with historical and potential dangers of radioisotopic agents.
放射性核素滑膜切除术 (RS) 被定义为在目标关节内注射放射性同位素制剂,以在增生性滑膜上引起纤维化。本研究旨在探讨 Yttrium(90) (Y(90)) 和 Rhenium(186) (Re(186)) 对接受 RS 的血友病儿童淋巴细胞的遗传毒性作用和恶性转化诱导作用。共纳入 40 例血友病患者。平均年龄为 16.4 +/- 6.2 岁(范围:8-40)。Y(90) 用于膝关节,Re(186) 用于其他关节。为了安全起见,在 RS 术前、术后第 3 天和第 90 天三个不同时间点进行细胞遗传学分析,以确定潜在的染色体变化。用二环氧丁烷(DEB 试验)刺激染色体断裂。在 RS 术前,23 例患者(67.6%)发现染色体断裂(CB)。我们发现,在 11 例 RS 术前无 CB 的患者中,有 9 例在接受放射性同位素 3 天后出现了 CB。此时,有 CB 的患者为 29 例(85.2%)。在第 90 天,只有 21 例患者(61.7%)出现 CB。第 3 天 CB 的平均频率略有增加,但无统计学意义。然而,第 3 天和第 90 天之间存在显著的下降趋势。Y(90) 和 Re(186) 的放射性核素滑膜切除术似乎不会对周围血淋巴细胞产生明显的遗传毒性作用。然而,即使在对四名患者进行了一年的重新评估后,在第 3 天和第 90 天之间 CB 的数量显著减少,以及暴露后新出现的 CB,都可以被视为年轻人群的警告信号。还应该指出,应向家属和患者适当告知放射性同位素制剂的历史和潜在危险。